The deadly dance of alveolar macrophages and influenza virus.


Journal

European respiratory review : an official journal of the European Respiratory Society
ISSN: 1600-0617
Titre abrégé: Eur Respir Rev
Pays: England
ID NLM: 9111391

Informations de publication

Date de publication:
Oct 2024
Historique:
received: 11 06 2024
accepted: 22 08 2024
medline: 31 10 2024
pubmed: 31 10 2024
entrez: 30 10 2024
Statut: epublish

Résumé

Influenza A virus (IAV) is one of the leading causes of respiratory infections. The lack of efficient anti-influenza therapeutics requires a better understanding of how IAV interacts with host cells. Alveolar macrophages are tissue-specific macrophages that play a critical role in lung innate immunity and homeostasis, yet their role during influenza infection remains unclear. First, our review highlights an active IAV replication within alveolar macrophages, despite an abortive viral cycle. Such infection leads to persistent alveolar macrophage inflammation and diminished phagocytic function, alongside direct mitochondrial damage and indirect metabolic shifts in the alveolar micro-environment. We also discuss the "macrophage disappearance reaction", which is a drastic reduction of the alveolar macrophage population observed after influenza infection in mice but debated in humans, with unclear underlying mechanisms. Furthermore, we explore the dual nature of alveolar macrophage responses to IAV infection, questioning whether they are deleterious or protective for the host. While IAV may exploit immuno-evasion strategies and induce alveolar macrophage alteration or depletion, this could potentially reduce excessive inflammation and allow for the replacement of more effective cells. Despite these insights, the pathophysiological role of alveolar macrophages during IAV infection in humans remains understudied, urging further exploration to unravel their precise contributions to disease progression and resolution.

Identifiants

pubmed: 39477353
pii: 33/174/240132
doi: 10.1183/16000617.0132-2024
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright ©The authors 2024.

Déclaration de conflit d'intérêts

Conflict of interest: All authors have nothing to disclose.

Auteurs

Camille David (C)

INSERM, Centre d'Etude des Pathologies Respiratoires (CEPR), UMR 1100, Tours, France.
Université de Tours, Tours, France.

Charles Verney (C)

INSERM, Centre d'Etude des Pathologies Respiratoires (CEPR), UMR 1100, Tours, France.
Université de Tours, Tours, France.
CHRU de Tours, Service de Médecine Intensive Réanimation, Tours, France.

Mustapha Si-Tahar (M)

INSERM, Centre d'Etude des Pathologies Respiratoires (CEPR), UMR 1100, Tours, France.
Université de Tours, Tours, France.

Antoine Guillon (A)

INSERM, Centre d'Etude des Pathologies Respiratoires (CEPR), UMR 1100, Tours, France antoine.guillon@univ-tours.fr.
Université de Tours, Tours, France.
CHRU de Tours, Service de Médecine Intensive Réanimation, Tours, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH